Coronary in-stent restenosis (ISR) is an adverse effect that occurs in 20-35% of patients who have undergone percutaneous coronary intervention (PCI) with stent implantation. The fact not all will develop ISR indicates genetic factors contribute to susceptibility. Previous studies reported various micro RNA (miRNA) molecules regulate biological processes underlying development, including miR-14...